C. David Nicholson - Dec 28, 2023 Form 4 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Role
Director
Signature
/s/ David Nicholson
Stock symbol
ATNM
Transactions as of
Dec 28, 2023
Transactions value $
$0
Form type
4
Date filed
12/29/2023, 05:24 PM
Previous filing
Nov 6, 2023
Next filing
Jun 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNM Stock Option (Right to Buy) Award $0 +70.3K $0.00 70.3K Dec 28, 2023 Common Stock 70.3K $5.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant.
F2 Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested.